This inventor holds 1 USPTO granted patent. Top assignee: Merck + Co., Inc.. Active years: 1992.
Company Filing History:
Years Active: 1992
Title: The Innovative Contributions of Julie J Mohan
Introduction
Julie J Mohan is a notable inventor based in Edison, NJ (US). She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target ocular conditions. Her work exemplifies the intersection of innovation and practical application in healthcare.
Latest Patents
Julie J Mohan holds a patent for the enantiospecific synthesis of - 5,6-Dihydro-4-(R-amino)-4H-thieno[2,3-b]-thiopyran-2-sulfonamide-7,7-dioxide. This compound is recognized as a potent carbonic anhydrase inhibitor, which is useful in the treatment of ocular hypertension and glaucoma. The S-(+)-enantiomer of this compound, which is the more active enantiomer, is prepared through a process that includes an intermediate step of an enantioselective reduction of a carbonyl group, utilizing an oxazaborolidine chiral catalyst.
Career Highlights
Julie is currently employed at Merck & Company, Inc., where she continues to advance her research and development efforts. Her innovative approach to drug synthesis has positioned her as a key figure in her field.
Collaborations
Throughout her career, Julie has collaborated with esteemed colleagues such as Thomas J Blacklock and Todd K Jones. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.
Conclusion
Julie J Mohan's contributions to medicinal chemistry and her innovative patent work highlight her role as a leading inventor in the field. Her dedication to improving healthcare through scientific advancements is commendable and continues to inspire future innovations.